RT Journal Article
SR Electronic
T1 757 Phase 1/2a clinical trial of BI-1808, a monoclonal antibody to tumor necrosis factor receptor 2 (TNFR2) as single agent and in combination with pembrolizumab
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A853
OP A853
DO 10.1136/jitc-2023-SITC2023.0757
VO 11
IS Suppl 1
A1 Rohrberg, Kristoffer Staahl
A1 Papai, Zsuzsanna
A1 Carneiro, Ana
A1 Lang, Istvan
A1 Yachnin, Jeffrey
A1 Lim, Sean
A1 Ny, Lars
A1 Lovendahl Eefsen, Rikke H
A1 Walter, Harriet
A1 Abel, Edvard
A1 Cleary, Kirstie
A1 Oldham, Robert
A1 Cragg, Mark
A1 Borggren, Marie
A1 Gertsson, Susanne
A1 Holmkvist, Petra
A1 Karlsson, Ingrid
A1 Martensson, Linda
A1 Nilsson, Jan Anders
A1 Wallin, Johan E
A1 Chisamore, Michael
A1 Frendeus, Bjorn
A1 Teige, Ingrid
A1 McAllister, Andres
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A853.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.